Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Change in Inventory (2016 - 2025)

Immucell's Change in Inventory history spans 16 years, with the latest figure at -$534636.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 53.71% year-over-year to -$534636.0; the TTM value through Dec 2025 reached $2.2 million, up 408.17%, while the annual FY2025 figure was $2.2 million, 408.17% up from the prior year.
  • Change in Inventory reached -$534636.0 in Q4 2025 per ICCC's latest filing, down from $1.5 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.5 million in Q3 2025 to a low of -$662278.0 in Q1 2024.
  • Average Change in Inventory over 5 years is $358742.8, with a median of $294100.0 recorded in 2021.
  • Peak YoY movement for Change in Inventory: surged 24826.58% in 2021, then plummeted 328.54% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $423004.0 in 2021, then soared by 70.39% to $720756.0 in 2022, then tumbled by 40.87% to $426178.0 in 2023, then plummeted by 181.62% to -$347829.0 in 2024, then crashed by 53.71% to -$534636.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Change in Inventory are -$534636.0 (Q4 2025), $1.5 million (Q3 2025), and $937060.0 (Q2 2025).